Stefan K.f. Schwabe, Executive Vice President R&D at SUPERNUS PHARMACEUTICALS INC (SUPN), sold 95,000 shares at $46.59 ($4.4M) on 2017-09-07, disclosed to the SEC on 2017-09-11.
Open-market sale of $4.4M SUPN by Executive Vice President R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SUPN | SELL | 2018-06-19 | $3.3M | — | Filing → |
| SUPN | SELL | 2015-07-29 | $50K | — | Filing → |
| SUPN | SELL | 2015-07-29 | $37K | — | Filing → |